He was VP, Bioinformatics at Variagenics - one of the first companies to work on pharmacogenomics/human genetic variation, and led a key project at the National Cancer Institute to integrate oncology care and research data. Adams is visiting faculty at the Center for Science and Industry at Bentley University, and has also held senior positions with Booz Allen Hamilton, Bridgewater Associates, and Good Start Genetics. Addario Lung Cancer Foundation (ALCF) in 2006, and then went on to found the Addario Lung Cancer Medical Institute (ALCMI) with her husband, Tony Addario, in 2008.Bonnie’s business acumen and skills honed in her first career as President of Olympian Oil Company and Commercial Fueling Network (CFN), as Past President of the CA Independent Oil Marketers Association (CIOMA) and as a community activist serving on diverse boards have all contributed to her work at ALCF in developing business strategies and being the Foundation’s patient voice at national/international conferences, on panels and boards, and to industry leaders, clinicians and policy makers.Bonnie’s personal interests include collecting wine, travel, sports (Go SF Giants!) and spending time with family and friends at Lake Tahoe. Aeffner received her DVM from the University of Veterinary Medicine, Hannover, Germany, and completed a 5-year combined Ph D and residency program in veterinary anatomic pathology from The Ohio State University. Aeffner currently is a Principal Pathologist at Amgen Inc. Prior to joining Amgen, she was the Associate Director of Pathology at Flagship Biosciences, a digital image analysis service provider.Professor and Director, Preclinical Therapeutics Core I am a Ph D scientist and professor within the HDFCCC, with over twenty-five years of experience working with mouse models of cancer, focusing on the TGFβ signaling pathway.
Program Director, Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis Lokesh Agrawal earned his Ph. from All India Institute of Medical Sciences, India and did his M. He was the first one to show the Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type I in primary CD4 cells using recombinant Adenoviruses and has developed assays to quantify viruses in blood.
Chrystal has worked in the field of digital pathology and most recently on digital health and its ability to enable value-based care models. Although thrust into a role that she had never envisioned for herself, she embraced it and now considers it to be her second career and a personal calling.
Chrystal has overseen product strategy and lifecycle management for eyes Finder, Leica Biosystems, and Aperio. Adams is the Chief Information Officer at Celmatix Inc., and has been working in biomedicine and data analytics for more than 20 years, encompassing work in computational biology, biomedicine, intelligence, finance, and biotechnology. Recognizing the critical need for education, empowerment, advocacy and research to help patients and families, especially those without resources and support, Bonnie and her family founded the Bonnie J.
His main interests include development and validation of human (both normal and cancer) biospecimen integrity markers using proteomic and molecular approaches and novel biomarkers for cancer treatment and diagnosis.
He directs and leads Biospecimen Research Network (BRN)-PI-led projects on human biospecimen integrity and biomarker development by studying preanalytical variables using proteomics and molecular approaches.